Literature DB >> 12067494

Altered mucin expression in the gastrointestinal tract: a review.

J R Jass1, M D Walsh.   

Abstract

Early studies of changes in mucin expression in disorders of the gastrointestinal tract focused on alterations in the carbohydrate chain. This review briefly considers the various mechanisms by which such alterations may come about: (a) normal variation, (b) sialic acid alterations, (c) defective assembly of carbohydrate side-chains, (d) changed expression of core proteins and (e) epithelial metaplasia. The availability of monoclonal antibodies to mucin core proteins adds a new dimension to mucin histochemistry. It is now possible to offer explanations for traditional mucin histochemical findings on the basis of lineage-specific patterns of mucin core protein expression. Changes in core protein expression are described in inflammatory, metaplastic and neoplastic disorders of the gastrointestinal tract. The possibility that mucin change could be important in the aetiology of some diseases such as ulcerative colitis and H. pylori gastritis is considered. It is more probable, however, that changes in mucin expression are secondary to reprogramming of cellular differentiation and altered cell turnover. As such they may serve as markers to explain pathogenesis and provide novel diagnostic and prognostic information.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12067494      PMCID: PMC6517815          DOI: 10.1111/j.1582-4934.2001.tb00169.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  32 in total

Review 1.  Intestinal candyfloss.

Authors:  Inka Brockhausen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Gallbladder mucin production and calcium carbonate gallstones in children.

Authors:  Craig Sayers; Judy Wyatt; Roger D Soloway; Donald R Taylor; Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2007-01-16       Impact factor: 1.827

3.  Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease.

Authors:  Sung-Hoon Ahn; Yatrik M Shah; Junko Inoue; Keiichirou Morimura; Insook Kim; Sunhee Yim; Gilles Lambert; Reiko Kurotani; Kunio Nagashima; Frank J Gonzalez; Yusuke Inoue
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

4.  RNA in situ hybridization in whole mount embryos and cell histology adapted for marine elasmobranchs.

Authors:  Nicole A Theodosiou
Journal:  J Vis Exp       Date:  2013-04-12       Impact factor: 1.355

5.  Gastric mucosal protection via enhancement of MUC5AC and MUC6 by geranylgeranylacetone.

Authors:  Su Youn Nam; Nayoung Kim; Chang Soo Lee; Kee Don Choi; Hye Seung Lee; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

6.  Effects of microbial phytase on mucin synthesis, gastric protein hydrolysis, and degradation of phytate along the gastrointestinal tract of growing pigs.

Authors:  Von G R Mesina; L Vanessa Lagos; Rommel C Sulabo; Carrie L Walk; Hans H Stein
Journal:  J Anim Sci       Date:  2019-02-01       Impact factor: 3.159

7.  Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice.

Authors:  Geneviève Coulombe; Caroline Leblanc; Sébastien Cagnol; Faiza Maloum; Etienne Lemieux; Nathalie Perreault; Gen-Sheng Feng; François Boudreau; Nathalie Rivard
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

Review 8.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 9.  Mammalian gut immunity.

Authors:  Benoit Chassaing; Manish Kumar; Mark T Baker; Vishal Singh; Matam Vijay-Kumar
Journal:  Biomed J       Date:  2014 Sep-Oct       Impact factor: 4.910

10.  Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.

Authors:  Jo Nadine Fleming; Howard M Shulman; Richard A Nash; Pamela Y Johnson; Thomas N Wight; Allen Gown; Stephen M Schwartz
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.